+ All Categories
Home > Documents > 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service...

2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service...

Date post: 15-Dec-2015
Category:
Upload: johnny-denton
View: 217 times
Download: 4 times
Share this document with a friend
Popular Tags:
62
2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s working group on stem cells and therapeutical cloning
Transcript
Page 1: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

2011Marek Vácha

There is a growing gulf between what medicine can do and what the health service can afford.

Richard Gardner, chair of the Royal Society´s working group on stem cells and therapeutical cloning

Page 2: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Totipotency

Plants

Page 3: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Totipotency: A Frog

Page 4: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Reproductive CloningIan Wilmut created Dolly the Sheep in 1997

Totipotency: Mammals

Page 5: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Reproductive Cloning and Therapeutic Cloning

Page 6: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Reproductive Cloning and Therapeutic Cloning

Page 7: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.
Page 8: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Reproductive Cloning

1996 sheep 1997 mouse 1998 cow 2000 pig 2002 cat 2005 dog

Page 9: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

cloned animals have also be re-cloned, and clones have reproduced sexually, although many cloned males are sterile (the earliest succesful clones were all female)

K.C., a cow cloned at the University of Georgia from the cell af a dead cow, gave birth in December 2004 to Sunshine, a calf who seems normal in every way

(Pierce, J., Randels, G., (2010) Contemporary Bioethics. Oxford University Press, NY, Oxford. p. 260)

Page 10: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Arguments for reproductive cloning

To allow an infertile couple to have a childThe Italian doctor Severino Antinori wants to offer cloning as a treatment for infertility. Critics have pointed out that anyone who was a clone of one of their parents would be under unknown psychological pressures throughout their childhood. Would they feel they were living up to the achievements of their 'original'? And how would a woman feel about bringing up a much younger version of the person she fell in love with?

To bring back a child killed in an accidentIn recent years, some bereaved families have contacted scientists asking them to clone a dead child. However, even if human cloning was possible, families might be distraught to discover their new baby was not exactly like their dead older brother or sister - and the 'replacement' child might suffer feelings of inferiority about being born purely to take the place of their dead sibling.

Page 11: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Arguments for reproductive cloning

To replicate the talents of exceptional human beings If Mother Theresa or Einstein could be genetically reproduced, their clones might choose very different paths in life, and disappoint the people who had chosen to create them.

Out of curiosity or to attempt some sort of immortality The scientist Richard Dawkins has expressed the desire to clone himself out of pure curiosity. Immortality through cloning seems an impossible goal because the clone’s experiences and thoughts would be their own, not those of the cloned adult.

To obtain a supply of stem cells The stem cells would be taken from a cloned embryo and used to rejuvenate and repair our bodies. The embryo would then be destroyed.

Page 12: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Arguments against reproductive cloning cloned humans may face problems of identity and

individuality because they are genetically identical to people who already

lived, and there may be expectations to be like their predecessors

cloning could contribute to the commodification of children and the commercialization of reproduction

cloning could lead to eugenics, favoring particular genetic traits

family relations might be confused, such as if the father and son were genetic twins, this also "brothers"

there might be a slippery slope impact on society, leading to such things as genetic enhancement and genetic control over the next generation

Page 13: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Embryonic Stem Cells

were firstly isolated from mice in1981.

Human Embryonic Stem Cells were firstly isolated in 1998 by James Thomson J.Thomson, Wisconsin

university funded by Geron corporation.

Dr. John Gearhart of Johns Hopkins University

James A. Thomson says he thought “long and hard” before doing stem cell research.

Page 14: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

James A. Thomson (2007)

His laboratory was one of two that reported a new way to turn ordinary human skin cells into what appear to be embryonic stem cells without ever using a human embryo.

The fact is, Dr. Thomson said in an interview, he had ethical concerns about embryonic research from the outset, even though he knew that such research offered insights into human development and the potential for powerful new treatments for disease.

“If human embryonic stem cell research does not make you at least a little bit uncomfortable, you have not thought about it enough,” he said. “I thought long and hard about whether I would do it.”

Page 15: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.
Page 16: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

James A. Thomson (2007)

Now with the new technique, which involves adding just four genes to ordinary adult skin cells, it will not be long, he says, before the stem cell wars are a distant memory. “A decade from now, this will be just a funny historical footnote,” Dr. Thomson said in the interview.

http://www.nytimes.com/2007/11/22/science/22stem.html?_r=1&ref=science&oref=slogin

Page 17: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Classification (ESC)Human embryonic stem cells,

Embryonic Stem Cell (ESC) Therapy - theoretically involves the use of cells extracted from a five day old in vitro fertilized embryo (in this embryo there is approximately 100 cells, ICM is 30 of them). ESCs have been scientifically substantiated to be pluripotent for all cell types.

(FSC)Human embryonic germ cells, Fetal Stem Cell (FSC) therapy involves the use of human fetuses

aborted between 1 and 3 months. Tissue with imbedded stem cells is scraped from the liver, neural or gonadal ridges. Commercial providers of these potentially pluripotent cell types do not scientifically classify the cell populations.

(ASC)Human Adult stem cells, ASC are undifferentiated, found among differentiated cell

types in a tissue or organ. ASC can renew themselves, and can differentiate to yield the major specialized cell types of the tissue or organ. Their primary role in a living organism is to maintain and repair the tissue in which they are found. There are approximately 20 types of ASC in the human body.

Page 18: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

iPS

= induced pluripotent stem cells by addition of four human human genes to

human skin cells they can be reprogrammed back to the state of stem cells from an early embryo, with the abuility to develop into every cell type in the body

Page 19: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

iPS

iPS thus promise to provide a source of immunologically compatible tissues for treating patients currently suffering from incurable genetic diseases such as Alzheimer´s disease, without encountering the ethical objections raised by using ESC from human embryos or cybrids

Page 20: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

„In the long-term the scientific view is that it will be possible to re-programme adult stem cells with the full potential of embryonic cells but without the morally contestable need to create an embryo.“

Liam Donaldson, the Chief Medical Officer in the UK

Page 21: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

ASC

Page 22: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Embryonic Stem CellsES cells that have proliferated in cell culture for 6 or more months without differentiating, and which have pluripotent and appear genetically normal, are referred to as an embryonic stem cell line.

Page 23: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Embryonic Stem Cells

Page 24: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Embryonic Stem Cells

Page 25: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Possible Sources of Embryonic Stem Cells

Surplus embryos Embryos made exclusively in order to receive ESC SCNT = Therapeutic Cloning

Page 26: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Preimplantation Diagnosis

Page 27: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Dr. Woo Suk Hwang

24/11 2005 Dr. Hwang is forced to to step down

female researchers in his own lab had supplied eggs for his research.

two key scientific papers in 2005, both published in Science Magazine, were found to have been fabricated.

August 2005 Snuppy, an Afghan hound was cloned by Dr. Hwang

Page 28: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Dr. Hwang

Dr Hwang was in March fired from his professorship at Seoul National University (SNU) and in May was charged with fraud and embezzlement. Dr Hwang had received millions of dollars' worth of funds from the state and private foundations for his research.

The downfall of Dr Hwang came as a big shock to Koreans, who had taken great pride in what appeared to be the pioneering work of the stem cell researchers at Seoul National University.

Dr Hwang at one point had 15,000 hard-core fans, who belonged to a "I love HWS" online community.

Page 29: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Definition of Human Embryo

A human embryo is a discrete entity that has arisen from either:

(i) the first mitotic division when fertilization of a human oocyte by a human sperm is complete or

(ii) any other process that initiates organized development of a biological entity with a human nuclear genome or altered human nuclear genome that has the potential to develop up to, or beyond, the stage at which the primitivestreak appears,

and has not yet reached 8 weeks of development since the first mitotic division.

Page 30: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Status of Embryo

Ontological personalism – Ontological personalism states that all human beings are human persons. On this view, the intrinsic quality of personhood begins at conception and is present throughout life Such individuals are not potential persons or "becoming" persons; they are persons by their very nature. There is no such thing as a potential person or a human non-person.

Empirical Functionalism – there is a diffrention between „being“ and „person“. According to this conception, the moral status of zygotes, embryos, foetuses and even infants is problematic. The person must need a minimal level of mental life. The embryo can not be determined by its potentiality or by what the embryo will become, but must be assessed in terms of what it is. Therefore it is not reasonable to think that the embryo has a moral status comparable to adults.

Page 31: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

biological species cognitive capacity moral agency sentience communal relationship

Page 32: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Empirical Functionalism

„person“

Page 33: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Ontological Personalism

„person“

Page 34: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Ontological personalism

it is morally acceptable to take stem cells when they do no serious harm to the subject, as is generally the case when tissues are taken from an adult organism the umbilical cord at the time of birth fetuses that have died from natural causes.

Page 35: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Arguments for obtaining Embryonic Stem Cells from embryos The prospects are beyond our scope Only 30-50% zygote implants. If Mother Nature

is so prodigal, we may not to bother with embryos.

individual is „in-dividium“, non-divisible. Human embryo is nothing than cluster of cells if we approved abortions, there is no discussion

about status of embryos utilitarianism: we have to consider the ethical

calculation, gains and losts: happy and healthy patient/destroyed embryo

Page 36: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Arguments for obtaining Embryonic Stem Cells from embryos If abortions are legal, protection of embryos

is inproportionate, inadequate ES cells are not embryos. These cells are no

more totipotent. If we already have these lines, they are cells, not embryos.

individuum is etymologically indivisible MZ twins could arise until the end of the second

week. Until this time we cannot speak about individuum

Page 37: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Arguments for obtaining Embryonic Stem Cells from embryos Argument of utilitarianism: on the one side

of the ethical scale is healthy happy patient, on the other side of the scale embryo which can not feel neither pain, nor pleasure

Page 38: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Should there be any age limits for using IVF? the world´s olders mothers were Omkari

Panwar and Rajo Devi of India, who both gave birth at age seventy in 2008

Page 39: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.
Page 40: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Arguments against obtainig Human Embryonic Stem Cells Embryo is not, embryos are. Every embryo

has a unique genetic design An Embryo has a potentiality to become an

adult human person, so we must treat an embryo as a person.

every embryo has two living beings, parents Aristotle: four „causes“ Immanuel Kant:

the problem of freedom difference between cost/value and dignity

Page 41: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Aristotle

causa materialis causa formalis causa efficiens causa finalis

Page 42: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Aristotle

causa materialis: „cluster of atoms“, „cluster of cells“, „C,H,O,N,“ etc.

causa formalis – form of living matter is a soul

causa efficiens „where from I came?“

causa finalis „what is goal of my life?“

Page 43: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

„Cluster of cells“

Five day old embryo is composed from150 – 200 cells,adult human from 5. 1014 cells

Page 44: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Germany

The German Parliament established the 2002 Stem Cell Act, which allows the import of hESCs for high-ranking research objectives.

These must be evaluated by the Robert Koch Institute, a federal institute in Berlin, and its central ethics committee for stem-cell research (http://www.rki.de).

Moreover, only hESC lines produced from surplus embryos from in vitro fertilization (IVF) before 1 January 2002 can be legally imported. This key date was chosen to ensure that no hESC lines are directly produced for German research; in other words, that no human embryos are destroyed 'on German order'

Page 45: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Regulation of Research in  EU

Germany: prohibition to destroy embryos for obtaining hES. Allowance to work with hES if the lines were created before 01/01 2002

22/05 2008 this import and usage was shifted to 01/05 2007

Page 46: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

USA

August 2000: scientists could apply for federal funding only for research utilizing 78 existing stem cell lines. the true number of available and suitable lines

appears to be closer to twenty than the higher number.

President Bush agreed to finance embryonic stem cell research, but limited federally financed research to 21 cell lines already in existence by 2001.

Page 47: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

USA

the restriction do not hamper the use of private funds for the other lines, only federal funds

09/03/2009 Barack Obama releases federal funds http://edition.cnn.com/video/#/video/offbeat/2009/03/12/moos.sesame.street.layoffs.cnn

23/08/2010 A federal district judge blocked President Obama’s 2009 executive order that expanded embryonic stem cell research, saying it violated a ban on federal money being used to destroy embryos.

Page 48: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.
Page 49: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

USA 23/08/2010

With the case back in his court, Judge Lamberth ruled that the administration’s policy violated the clear language of the Dickey-Wicker Amendment, a law passed annually by Congress that bans federal financing for any “research in which a human embryo or embryos are destroyed, discarded or knowingly subjected to risk of injury or death.”

The Obama administration said that its rules abided by the Dickey-Wicker Amendment because the federal money would be used only once the embryonic stem cells were created but would not finance the process by which embryos were destroyed. The judge disagreed, writing that embryonic stem cell research “necessarily depends upon the destruction of a human embryo.”

http://www.nytimes.com/2010/08/24/health/policy/24stem.html?pagewanted=2&_r=1&ref=science

Page 50: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

http://www.nytimes.com/2008/12/04/us/04embryo.html?_r=1

Page 51: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Ms. Best said her nine embryos “have the potential to become beautiful people.”

The thought of giving them up for research “conjures all sorts of horrors, from Frankenstein to the Holocaust,” she said, adding that destroying them would be preferable.

Her teenage daughter favors letting another couple adopt the embryos, but, Ms. Best said, she would worry too much about “what kind of parents they were with, what kind of life they had.”

Page 52: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

„Solutions that typically are not offered“ Smaller numbers of patients wished for

solutions that typically are not offered. Among them were holding a small ceremony

during the thawing and disposal of the embryos, or

having them placed in the woman’s body at a time in her cycle when she would probably not become pregnant, so that they would die naturally.

Page 53: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Some people pay storage fees for years and years.

Others stop paying and disappear, leaving the clinic to decide whether to maintain the embryos free or to get rid of them. “They would rather have you pull the trigger on

the embryos,” Dr. Sauer said. “It’s like, ‘I don’t want another baby, but I don’t have it in me; I have too much guilt to tell you what to do, to have them discarded.’ ”

Page 54: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

SCNT

this technique is too elaborate, and hence too expensive for routine use

technique might be more properly called „research cloning“

Page 55: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Human EmbryoLuis Santamaría, U.A.M., Spain

Human embryos are not: some other type of animal organism, like a pre-

human entity neither are they a part of an organism, like a heart,

a kidney, or a skin cells nor again are they a disorganized aggregate, a

mere clump of cells awaiting some magical transformations

rather, a human embryo is a whole living member of the species Homo sapiens in the earliest of his or her natural development

Page 56: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Embryo science, Embryo technology, Embryo ethicsLuis Santamaría, U.A.M., Spain Embryo science

tells us what the embryos are and when they begin

Embryo technologies represent the abilities of researchers to do

things to or with embryos they can make embryos in lab, by IVF or by

cloning they can keep embryos alive in the lab whether

in culture, or indefinitely by freezing they can destroy these embryos

Page 57: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Embryo science, Embryo technology, Embryo ethicsLuis Santamaría, U.A.M., Spain Embryo ethics

are such manipulation morally right? it is not uncommon to hear embryo

researchers claim that only science should have a say what science does, and that ethics, religion and politics have no business in the concerns of science

it is true that moral philosophy cannot say what embryo is nor has anything to say about what can be done with an embryo

Page 58: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Geoffrey Chu, 2003

Rasko correctly asserts that certain medical research is unethical and unjustifiable (i.e. Nazi experiments) and should always be prohibited, regardless of significant potential gains.

Accepting this premise renders utilitarian arguments in favour of ESC research irrelevant if the human embryo is considered to be an individual human being.

Utilitarian arguments have serious limitations because the eventual outcome of benefits and harms is initially uncertain and may remain unclear for a substantial period − decades or longer.

http://www3.interscience.wiley.com/journal/118897797/abstract?CRETRY=1&SRETRY=0

Page 59: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Geoffrey Chu, 2003

In the early phases of this continuum, we casually redefine 'human' to suit our personal agendas. (…) Emergence of the embryonic streak on day 14 is another unfortunate arbitrary definition of who is human.

Those who have lost part of their cortex from a stroke or Alzheimer's Disease are no less human than they were beforehand.

http://www3.interscience.wiley.com/journal/118897797/abstract?CRETRY=1&SRETRY=0

Page 60: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Cybrids

applications have been made by three teams of UK researchers to the HFEA for licences to use rabbit, cow and goat eggs to create cytoplasmatic hybrid embryos, so-called cybrids

the proposal, which has found widespread support in the bioscience community, was the subject of a public consultation exercise, which resulted in the HFEA giving „in principle“ approval for the use of the technique in 2007

Page 61: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Cybrids

Page 62: 2011 Marek Vácha There is a growing gulf between what medicine can do and what the health service can afford. Richard Gardner, chair of the Royal Society´s.

Recommended